FindTrial
Sign In

Effect of Dashmooldi kwath granules and Punarnavashtak kwath granules in Benign Prostate Hyperplasia(BPH)

A Comparative clinical study to evaluate the efficacy between Dashmooladi kwath granules and Punarnavashtak kwath granules in the management of Vatashtheela w.s.r. to Benign Prostate Hyperplasia(BPH)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048164
Enrollment
40
Registered
2022-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved college,Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with signs and symptoms of benign prostate hyperplasia 2)USG diagnosed cases of benign prostate hyperplasia 3)Residual urine less than 120 ml

Exclusion criteria

Exclusion criteria: 1)Residual urine more than 120 ml 2) Patients suffering from prostatic carcinoma,bladder neck stenosis,prostatic calculi,diabetes mellitus,tuberculosis,prostatic bleeding,HIV,complete urine retention and malignancy.

Design outcomes

Primary

MeasureTime frame
1)Improvement in incomplete emptying,frequency,intermittency,urgency,weak streaming,straining and nocturia. 2)Decrease in residual urine volumeTimepoint: 8 weeks—

Secondary

MeasureTime frame
1)Improvement in incomplete emptying,frequency,intermittency,urgency,weak streaming,straining and nocturia. 2)Decrease in residual urine volumeTimepoint: 2 weeks , 4 weeks and 6 weeks—

Countries

India

Contacts

Public ContactDrRavi Sharma

Madan Mohan Malviya Government Ayurved College,Udaipur

rspgkcj2015@gmail.com9414419259

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026